跳至主要内容
临床试验/IRCT138706131155N3
IRCT138706131155N3已完成3 期

A randomized placebo-controlled double blind study to evaluate intradermal vaccination in hepatitis B healthy carriers to eliminate virus

guilan university of medical siences0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Including hepatitis B healthy carriers (positive HBsAg with normal alanine transaminase level).
  • Excluding D.M or other autoimmune diseases, chronic or serious medical diseases, malnutrition, positive for anti-HIV, anti-HCV and Anti-HDV, pregnancy, receiving any antiviral medication, alcohol intake daily, refusing to give informed consent and so increase in ALT or getting a serious disease during the project and volunteer refusing to continue.

排除标准

  • 未提供

研究者

发起方
guilan university of medical siences

相似试验